Furthermore, in the recent paper by Dornieden et al. on the profiling of lymphocytes homing peri- and tumorous tissues, it was reported that CD8-positive cells from RCC tumor tissue expressed simultaneously PD-1 and TOX (Dornieden et al. 2021). The gene discussed is CD8A; the disease is neoplasm.